Except for ACSL3 and ACSL4, FAM genes were either downregulated in tumor tissue or found no significant difference, indicating that the function of fatty acid degradation was impaired in tumor of HBV-associated HCC. This evidence concerns the gene USP9X and hepatocellular carcinoma.